Neuroscientific Biopharmaceuticals Ltd - Asset Resilience Ratio

Latest as of June 2025: 42.83%

Neuroscientific Biopharmaceuticals Ltd (NSB) has an Asset Resilience Ratio of 42.83% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Neuroscientific Biopharmaceuticals Ltd total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

AU$7.27 Million

≈ $5.14 Million USD Cash + Short-term Investments

Total Assets

AU$16.96 Million

≈ $12.00 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Neuroscientific Biopharmaceuticals Ltd's Asset Resilience Ratio has changed over time. See what is Neuroscientific Biopharmaceuticals Ltd's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Neuroscientific Biopharmaceuticals Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see NSB stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$7.27 Million	42.83%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$7.27 Million	42.83%

Asset Resilience Insights

Very High Liquidity: Neuroscientific Biopharmaceuticals Ltd maintains exceptional liquid asset reserves at 42.83% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Neuroscientific Biopharmaceuticals Ltd Industry Peers by Asset Resilience Ratio

Compare Neuroscientific Biopharmaceuticals Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Royalty Pharma Plc NASDAQ:RPRX	Biotechnology	0.10%
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	3.28%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	4.52%
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	35.56%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for Neuroscientific Biopharmaceuticals Ltd (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Neuroscientific Biopharmaceuticals Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	42.83%	AU$7.27 Million ≈ $5.14 Million	AU$16.96 Million ≈ $12.00 Million	-48.30pp
2024-06-30	91.14%	AU$4.95 Million ≈ $3.51 Million	AU$5.44 Million ≈ $3.85 Million	-1.69pp
2023-06-30	92.83%	AU$4.91 Million ≈ $3.48 Million	AU$5.29 Million ≈ $3.74 Million	-0.43pp
2022-06-30	93.26%	AU$7.22 Million ≈ $5.11 Million	AU$7.74 Million ≈ $5.47 Million	-2.25pp
2021-06-30	95.51%	AU$14.16 Million ≈ $10.02 Million	AU$14.83 Million ≈ $10.49 Million	+7.58pp
2020-06-30	87.94%	AU$3.29 Million ≈ $2.33 Million	AU$3.74 Million ≈ $2.64 Million	-2.04pp
2019-06-30	89.97%	AU$4.61 Million ≈ $3.26 Million	AU$5.12 Million ≈ $3.63 Million	--

pp = percentage points

About Neuroscientific Biopharmaceuticals Ltd

AU:NSB Australia Biotechnology

Market Cap

$24.71 Million

AU$34.92 Million AUD

Market Cap Rank

#24350 Global

#1004 in Australia

Share Price

AU$0.11

Change (1 day)

+0.00%

52-Week Range

AU$0.05 - AU$0.25

All Time High

AU$0.52